1. Home
  2. HDSN vs ZNTL Comparison

HDSN vs ZNTL Comparison

Compare HDSN & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HDSN
  • ZNTL
  • Stock Information
  • Founded
  • HDSN 1991
  • ZNTL 2014
  • Country
  • HDSN United States
  • ZNTL United States
  • Employees
  • HDSN N/A
  • ZNTL N/A
  • Industry
  • HDSN Industrial Specialties
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • HDSN Consumer Discretionary
  • ZNTL Health Care
  • Exchange
  • HDSN Nasdaq
  • ZNTL Nasdaq
  • Market Cap
  • HDSN 270.3M
  • ZNTL 227.0M
  • IPO Year
  • HDSN 1994
  • ZNTL 2020
  • Fundamental
  • Price
  • HDSN $5.28
  • ZNTL $2.92
  • Analyst Decision
  • HDSN Hold
  • ZNTL Buy
  • Analyst Count
  • HDSN 4
  • ZNTL 8
  • Target Price
  • HDSN $7.31
  • ZNTL $10.50
  • AVG Volume (30 Days)
  • HDSN 635.1K
  • ZNTL 997.7K
  • Earning Date
  • HDSN 11-04-2024
  • ZNTL 11-12-2024
  • Dividend Yield
  • HDSN N/A
  • ZNTL N/A
  • EPS Growth
  • HDSN N/A
  • ZNTL N/A
  • EPS
  • HDSN 0.65
  • ZNTL N/A
  • Revenue
  • HDSN $247,331,000.00
  • ZNTL $40,560,000.00
  • Revenue This Year
  • HDSN N/A
  • ZNTL N/A
  • Revenue Next Year
  • HDSN N/A
  • ZNTL N/A
  • P/E Ratio
  • HDSN $8.09
  • ZNTL N/A
  • Revenue Growth
  • HDSN N/A
  • ZNTL N/A
  • 52 Week Low
  • HDSN $5.28
  • ZNTL $2.66
  • 52 Week High
  • HDSN $15.24
  • ZNTL $18.07
  • Technical
  • Relative Strength Index (RSI)
  • HDSN 28.86
  • ZNTL 38.90
  • Support Level
  • HDSN $5.29
  • ZNTL $3.01
  • Resistance Level
  • HDSN $6.00
  • ZNTL $4.00
  • Average True Range (ATR)
  • HDSN 0.22
  • ZNTL 0.27
  • MACD
  • HDSN -0.00
  • ZNTL -0.07
  • Stochastic Oscillator
  • HDSN 13.25
  • ZNTL 8.44

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at a customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Share on Social Networks: